SecBot SecBot
8-K ·Filed Feb 25, 2026

SDGR

Schrodinger, Inc.
MIXED
Impact 6/10
Horizonmonths Processed8mo ago SEC0001490978-26-000009
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

While the strong 2025 revenue growth and improved profitability are positive, traders should focus on the accelerating transition to hosted software, which will create a headwind for reported software revenue growth in the near term. Monitor ACV growth (guided at 10-15% for 2026) and net dollar retention as better indicators of underlying software business health. The path to positive adjusted EBITDA by 2028 is a key long-term milestone.

DirectionMixed
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
SDGR ▲ +4.23% at T+60d
NEUTRAL call +4.23% · α vs SPY -3.94% · entry $12.76 → $13.30
Entry = T+0 close
Feb 25, 2026
via day close
T+1d
-5.49%
call -5.49% · α -5.01%
$12.06
settled 8mo ago
T+5d
+2.12%
call +2.12% · α +3.28%
$13.03
settled 8mo ago
T+20d
-9.33%
call -9.33% · α -2.91%
$11.57
settled 7mo ago
T+60d
+4.23%
call +4.23% · α -3.94%
$13.30
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Schrodinger reported strong full-year 2025 financial results with total revenue of $255.9 million, representing 23.3% year-over-year growth, driven by a 10.6% increase in software revenue and a significant jump in drug discovery revenue. The company is accelerating its transition to a hosted software model, which will shift revenue recognition from upfront to ratable, potentially reducing near-term GAAP revenue despite stable ACV growth. Management provided 2026 guidance and 2028 objectives, including a path to positive adjusted EBITDA.

Key Financial Metrics

Revenue
$255.9M
+23.3% YoY
EPS
$-1.41
Guidance
$273M-$293M
initiated
Gross Margin
55.7%

Key Facts

  • Full-year 2025 total revenue was $255.9 million, up 23.3% YoY.
  • Software revenue grew 10.6% to $199.5 million, while drug discovery revenue more than doubled to $56.4 million.
  • Net loss narrowed to $103.3 million from $187.1 million in 2024.
  • The company is accelerating its transition to hosted software, which will shift revenue recognition from upfront to ratable, impacting near-term GAAP revenue.
  • 2025 Software ACV was $198.5 million, up 4.0% YoY, with net dollar retention at 100%.
  • 2026 guidance includes Software ACV of $218M-$228M (10-15% growth) and drug discovery revenue of $55M-$65M.
  • The company aims for positive adjusted EBITDA by the end of 2028.

Financial Impact

Total revenue increased by $48.3 million YoY to $255.9 million, with drug discovery revenue contributing $29.2 million of that growth. The shift to hosted revenue recognition is expected to create a short-to-medium term headwind for software revenue growth despite strong underlying ACV growth.

revenueepsmarginscashFlow

Segment Breakdown

SegmentRevenueGrowth
Software$199.5M+10.6%
Drug Discovery$56.4M+107.4%

Risk Factors

  • The transition to hosted software will likely cause reported software revenue to decline in the short-to-medium term, which could pressure the stock despite stable ACV.
  • Net dollar retention for commercial customers declined to 100% in 2025 from 113% in 2024, indicating reduced expansion revenue from the existing customer base.
  • The company remains unprofitable on a GAAP basis, with a net loss of $103.3 million in 2025, and positive adjusted EBITDA is not expected until 2028.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001490978-26-000009
Document: sdgr-20260225.htm0001490978-26-000009
Document: 0001490978-26-000009-index-headers.html0001490978-26-000009
Document: 0001490978-26-000009-index.html0001490978-26-000009
Document: 0001490978-26-000009.txt0001490978-26-000009
7 reports for SDGR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SDGR — sortable, filterable
TypeNow
Jun 29, 2026
17w ago
8-K
BULLISH ★ 6/10
$16.25 $29.23▲ +79.88%▲ +77.06%$24.50 (+50.77%)
Jun 23, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$15.33 $30.24▲ +97.26%▲ +94.42%$24.50 (+59.82%)
May 20, 2026
22w ago
8-K
NEUTRAL ★ 4/10
$13.23 $17.40▲ +31.52%▲ +27.22%$24.50 (+85.19%)
May 5, 2026
24w ago
8-K
MIXED ★ 5/10
$12.98 $15.14▲ +16.64%▲ +14.58%$24.50 (+88.75%)
Apr 16, 2026
27w ago
Insider Cluster
BEARISH ★ 6/10
$12.06 $16.41▼ −36.07%▼ −29.02%$24.50 (−103.15%)
Mar 4, 2026
33w ago
Insider Cluster
NEUTRAL ★ 3/10
$13.12 $14.16▲ +7.93%▼ −2.16%$24.50 (+86.74%)
Feb 25, 2026
34w ago
8-K
MIXED ★ 6/10
$12.76 $13.30▲ +4.23%▼ −3.94%$24.50 (+92.01%)
Showing 7 of 7

US Market Status

Market Closed — Opens Wed (11h 51m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 25, 2026